Background:
Materials and methods

Data sources
The National Health Insurance (NHI) program in Taiwan is a universal insurance system established by the Bureau of National Health Insurance in the Department of Health and has been implemented since 1995. The insurance program provides health care to 99% of 23.74 million people and has a contract with 97% of the hospitals and clinics in the Taiwan (Cheng 2009 ). The National Health Research Institute (NHRI) comprises the registration and claims data of 1,000,000 individuals who have been systematically selected from all insured enrollees. The NHRI in Taiwan manages the NHI data bank. The NHI dataset included information on registry of medical facilities, details of inpatient orders, ambulatory care, dental services, prescription drugs, physicians providing the services, and the registration file with scrambled identification. Diagnoses are coded according to the International Classification of Diseases, 9 th Revision, Clinical Modification (ICD-9-CM). This cohort study was approved by the Ethics Review Board of China Medical University (CMU-REC-101-012).
Study subjects
In the study cohort, we selected patients with newly identified non-apnea SD (ICD-9-CM codes 307.4 and 780.5) from January 1997 to December 2001. The date of non-apnea SD diagnosis was used as the index date. We excluded patients who had sleep apnea syndrome (SA) 780.53, and 780.57 ) and patients with a history of ACS before the index date. The comparison cohort comprised randomly selected age-and sex-matched individuals without history of non-apnea SD, SA, and ACS. The control to case ratio was 2:1.
Outcome measures
The person-years of follow-up were estimated for study subjects from index date to the ACS (ICD-9-CM codes 410 and 411.1) diagnosis or censoring because of death during hospitalization, loss to follow-up, withdrawal from the insurance system, or to the end of December 31, 2010. Comorbidities included in our study were hypertension (ICD-9-CM codes 401-405), diabetes (ICD-9-CM codes 250), hyperlipidemia (ICD-9-CM codes 272), cerebrovascular disease (CVA) (ICD-9-CM codes 430-438), chronic Obstructive Pulmonary Disease (COPD) (ICD-9-CM codes 490-496), and heart failure (ICD-9-CM codes 428).
Statistical analysis
All statistical analyses were performed using SAS 9.2 (SAS Institute Inc., Cary, NC, USA). Comparisons of continuous variables among two groups were made by t-test, and test was used to compare categorical data. Cox proportional hazard models were to examine the association of non-apnea SD with subsequent risk of ACS.
Meanwhile, we calculated hazard ratios (HRs) with 95% confidence intervals (CIs).
The proportionate distribution of demographic characteristics and comorbidities between the cohorts with and without non-apnea SD were compared and tested using the test. The mean ages between both cohorts were measured and tested using t-test. We assessed the overall, sex-, and age-specific incidence of ACS for patients with non-apnea SD and for subjects in the comparison cohort.We used Cox-proportional hazard regression models to estimate the HRs of developing ACS in non-apnea SD cohort compared with the comparison cohort. Furthermore, Cox proportion hazard regression models were used to assess the effects of non-apnea SD on the risk of ACS while adjusting variables which were significantly associated through the analyses. To assess the difference in the ACS-free rates between the two cohorts, the Kaplan-Meier analysis and log-rank test were applied.
Results
In our study, the prevalence of Non-SD patients from 1997 subjects without non-apnea SD. Nearly half of the patients with non-apnea SD were 41-65 years of age, and 63.7% were female. The distribution of age and sex were similar between the two cohorts. The non-apnea SD cohort had higher prevalence of hypertension, diabetes, hyperlipidemia, CVA, COPD, and heart failure than the comparison cohort (p<0.0001). (Table 1) During the follow-up period, the overall incidence of ACS was higher in patients with non-apnea SD than in patients without non-apnea SD (14.6 vs. 7.66 per 10,000
person-years). The risk of ACS was 1.91-fold higher for patients with non-apnea SD than for patients without non-apnea SD. After adjusting covariates, the risk of developing ACS remained significant for patients with non-apnea SD (HRs=1.34; 95% CIs=1.21-1.50). Male had higher incidence of ACS than female in both cohorts and 57% increase of ACS risk comparing with female. The incidence of ACS increased with age in both cohorts. The impact of non-apnea SD on the risk of ACS was higher in the young adults than in the middle-aged adults and in the eldery ﹝≤ The incidence of ACS increased while having any comorbidity in both cohorts
However, the effect of non-apnea sleep disorders on the risk of developing ACS decreased while the subjects had any of comorbidities. (Table 3 ) Figure 1 exhibits the Kaplan-Meier curves of freedom from ACS in both cohorts. There was a significant difference in ACS occurrence between the patients with non-apnea SD and those without non-apnea SD (log-rank test, p<0.0001).
Discussion
ACS are life-threatening diseases that remain high morbidity and mortality despite advances in treatment (Kolansky 2009 ). The risk factors of ACS are similar to those for stroke and include older age, hypertension, hyperlipidemia, diabetes, cigarette smoking, and lack of physical activity. In addition, obstructive sleep apnea is well documented to be associated with an increased risk of cardiovascular disease and stroke. Obstructive sleep apnea is strongly associated with obesity, insulin resistance, dyslipidemia, and hypertension as well (Lattimore, Celermajer et al. 2003; Shamsuzzaman, Gersh et al. 2003) . Moreover, screening for and treating obstructive sleep apnea in patients with coronary artery disease who may undergo percutaneous coronary intervention may result in decreased cardiac death (Cassar, Morgenthaler et al. 2007 ).
Much of the attention in the field of sleep disorders focuses on the obstructive sleep apnea syndrome. There is scarce research to address the association between non-apnea SD and cardiovascular diseases. To our best knowledge, this is the first epidemiologic data for Asian people to address the association between non-apnea SD and ACS. In our study, the year prevalence rate of non-apnea SD increased from 0.47% in 1997 to 4.1% in 2001, which may explain the insured people progressively sought for medical treatment for his/her sleep disorders. However, the prevalence seemed lower than previous studies varying from 10% to 40% (Ü STÜ N, PRIVETT et al. 1996; Simon and VonKorff 1997; Leger, Guilleminault et al. 2000; Ohayon and Hong 2002; Laugsand, Vatten et al. 2011) . These subjects suffering sleep disorders sought for medical treatment in our study, which may become underestimated.
Importantly, insomniacs rarely visited a physician to discuss their sleep problems and four out of ten insomniacs self-medicated with either over-the-counter medications or with alcohol (Ancoli-Israel and Roth 1999). The majority of non-apnea SD patients were middle-aged adults, which maybe associated with psychological stress (Medinger and Varghese 1981) . There was significant association between non-apnea SD and comorbidites such as hypertension, diabetes, hyperlipidemia, cerebrovascular diseases (CVA), chronic obstructive pulmonary diseases (COPD), and heart failure in our study, which is consistent with previous studies. (Budhiraja, Parthasarathy et al. 2012; Fernandez-Mendoza, Vgontzas et al. 2012; Nakazaki, Noda et al. 2012; Plantinga, Rao et al. 2012) The majority of the non-apnea SD cohort was female in our study. A female preponderance of insomnia was found in several studies and Zhang's meta-analysis confirmed a female excess in the risk of insomnia. (Henderson, Jorm et al. 1995; Li, Wing et al. 2002; Zhang and Wing 2006) After adjusting age and comorbidities, male with non-apnea SD had a higher risk of developing ACS than female in our study.
This finding was consistent with a series of studies. (Sinha and Tremmel 2007; Ostadal and Ostadal 2012) The impact of non-apnea SD on the risk of ACS was higher in the young adults than in the middle-aged adults and in the eldery. However, the risk of ACS increased following the age after adjusting gender and comorbidities.
The probable explanation is that the elderly have higher proportion of comorbidities interacting with non-apnea SD to develop ACS. This epiphenomenon can be explained by that the risk of ACS increased while the subjects had more comorbidities in addition to non-apnea SD in our study. The effect of non-apnea SD on the risk of developing ACS decreased while the subjects had any of comorbidities because of effect modification. Comorbidities such as hypertension, diabetes, hyperlipidemia, CVA, COPD, and heart failure had increased the risk of ACS as well in our study.
Moreover, the non-apnea SD patients with more than 3 comorbidities had 5.35 folds risk of developing ACS than without comorbidity.
The non-apnea SD cohort had 1.91-fold risk increase of subsequent ACS than the cohort without non-apnea SD. Moreover, the risk of developing ACS remained significant for patients with non-apnea SD (HRs=1.34; 95% CIs=1.21-1.50), after adjusting covariates. The results were fairly robust in different multivariate models. discovered that insomnia and short sleep duration were associated with atherosclerosis risk leading to cardiovascular disease. (Nakazaki, Noda et al. 2012 ) Atherosclerosis and incident hypertension may predispose to suddenly reduced or occluded blood flow of the coronary arteries, which may explain the subjects with non-apnea sleep disorders have a higher risk of developing ACS in our study.
However, there were some limitations in this study. First, the NHIRD does not provide detailed information of the patients such as their smoking habits, alcohol consumption, body mass index, physical activity, socioeconomic status, and family history. All of these are potential confounding factors in this study. However, these factors maybe randomly distributed at these two large cohorts. Second, the evidence derived from a retrospective cohort study is generally of a lower methodological quality than that from randomized trials because a retrospective cohort study design is subject to some biases related to adjustment for confounds. Despite our meticulous study design with adequate control of confounding factors, a key limitation was that bias could still remain because of possible unmeasured or unknown confounders.
Despite of these limitations, the strength of this study is to provide a nationwide population-based cohort longitudinal study for Asian people regarding non-apnea SD on the risk of subsequent ACS events. In conclusion, the subjects with non-apnea sleep disorders have a higher risk of developing ACS, which increased following the age. Better management of sleep disorders may be important for prevention of ACS.
